Cipro and Abacavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cipro (ciprofloxacin hydrochloride) and Abacavir (abacavir sulfate). Common drug interactions include schizophrenia among females and adrenal insufficiency among males.

The phase IV clinical study analyzes what interactions people have when they take Cipro and Abacavir. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

What is Abacavir?

Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.



On Aug, 08, 2026

54 people who take Cipro and Abacavir together, and have interactions are studied.

Cipro and Abacavir drug interactions.

What are the common drug interactions of Cipro and Abacavir, by gender? *:

female:

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  2. Total lung capacity increased
  3. Vomiting
  4. Wheezing (a high-pitched whistling sound made while you breath)
  5. Lung neoplasm malignant (cancer tumour of lung)
  6. Lung neoplasm (tumour of lung)
  7. Asthma
  8. Back pain
  9. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  10. Coeliac disease (simple food intolerance)

male:

  1. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  2. Hepatic enzyme increased
  3. T-cell lymphoma (a blood cell cancer)
  4. Abdominal pain
  5. Abnormal behaviour
  6. Abscess neck (neck abscesses)
  7. Agitation (state of anxiety or nervous excitement)
  8. Alcohol abuse
  9. Apathy
  10. Bone density decreased

What are the common drug interactions of Cipro and Abacavir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthma
  2. Back pain
  3. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  4. Coeliac disease (simple food intolerance)
  5. Constipation
  6. Drug hypersensitivity
  7. Drug ineffective
  8. Drug intolerance (drug sensitivity)
  9. Erythema (redness of the skin)
  10. Fatigue (feeling of tiredness)

40-49:

  1. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  2. Hepatic enzyme increased
  3. Lymphadenopathy (disease or enlargement of lymph nodes)
  4. T-cell lymphoma (a blood cell cancer)
  5. Chronic kidney disease
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Renal failure (kidney dysfunction)
  10. Renal failure acute (rapid kidney dysfunction)

50-59:

  1. Blood bilirubin increased
  2. Jaundice cholestatic
  3. Nasal polyps (masses that develop in the lining of the nose)
  4. Nausea (feeling of having an urge to vomit)
  5. Oedema peripheral (superficial swelling)
  6. Pneumonia
  7. Psychotic disorder
  8. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  9. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  10. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)

60+:

  1. Immunosuppressant drug level increased

What are the existing conditions these people have? *

  1. Psychotic Disorder: 34 people, 62.96%
  2. Hypomania (a mild form of mania, marked by elation and hyperactivity): 34 people, 62.96%
  3. Depression: 32 people, 59.26%
  4. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 31 people, 57.41%
  5. Pain In Extremity: 9 people, 16.67%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and Abacavir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cipro and Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abacavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin hydrochloride and abacavir sulfate (the active ingredients of Cipro and Abacavir, respectively), and Cipro and Abacavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: